糖尿病肾病的发病机制及应对策略终稿-带解说词 -En.pptx

糖尿病肾病的发病机制及应对策略终稿-带解说词 -En.pptx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Pathogenesis and prevention of diabetic kidney diseaseOutline231Epidemiology of diabetic kidney disease(DKD) Pathogenesis of DKD strategy for prevention Renal benefit data of DLAMICRON MRPrevention of diabetes and its long-term complicationsPrimary preventionPrevention of diabetesCVDMacrovascularSecondary preventionPrevention of long-term complications retinopathyDKDneuropathyMicrovascularTertiary preventionPrevention the progression of long-term complications中华医学会糖尿病学分会.中华糖尿病杂志.2014;6(7):447-98.DKD—major diabetic microvascular complications neuropathyRetinopathyDKDDKD (diabetic kidney disease) diabetes induced chronic kidney disease GFR≤60ml/min/1.73m2or ACR ≧30mg/g for >3 months糖尿病肾病防治专家共识(2014版)Epidemiology of DKD in China 2009 to 2012Hospital-based T2DMCommunity-basedT2DMDKD prevalence30%-50%DKD prevalence40%糖尿病肾病防治专家共识(2014版)Trends in CKD patients Related to Diabetes and to Glomerulonephritis among HospitalizedPatients in ChinaZhang L, et al. N Engl J Med. 2016 Sep 1;375(9)905-6.Gradual decrease in eGFR in T2DMDevelopment and progression of DKDdecrease in eGFR and increase in UACR end-stagepreearlyovertalbuminuria(mg/d)‘eGFR(ml/min/1.73m2)Diabetic duration (years)Clifford J Bailey,et al. British Journal of Diabetes and Vascular Disease. 2012;12(4):167-171.DKD is the leading cause of ESRD2015 ANNUAL DATA REPORT of ESRD in USAFigure 1.16 Trends in (a) number of prevalent ESRD cases (in thousands) and (b) adjusted* prevalence (per million) of ESRD, by primary cause of ESRD, in the U.S. population, 1996-2013/2015/download/vol2_USRDS_ESRD_15.pdfHigh mortality in DKD-ESRD patientsSteno diabetes center cohort Mortality 8% (control group) vs. 30% (DKD group) 50% mortality in DKD group due to ESRD42761 T2DM followed by 4 years with progression of albuminuriaESRD increased by 30.6% and motality increased by 30.9%DIAMETRIC database19.5% DKD progressed to ESRD2.5 fold of that to CVD and 1.5 fold ofall-cause mortality ESRD.谢席胜, 等. 中国中西医结合肾病杂志, 2013; 14(10): 937-940Highe

文档评论(0)

a13355589 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档